{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:30Z","timestamp":1761895530870},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2002,12,1]],"date-time":"2002-12-01T00:00:00Z","timestamp":1038700800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Drug React Toxicol Rev"],"published-print":{"date-parts":[[2002,12]]},"DOI":"10.1007\/bf03256197","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T08:29:22Z","timestamp":1345105762000},"page":"205-217","source":"Crossref","is-referenced-by-count":22,"title":["Are Hypoglycaemia and Other Adverse Effects Similar Among Sulphonylureas?"],"prefix":"10.1007","volume":"21","author":[{"given":"Maribel","family":"Salas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime J.","family":"Caro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"BF03256197_CR1","first-page":"509","volume-title":"Joslin\u2019s diabetes mellitus","author":"HE Lebovitz","year":"1994","unstructured":"Lebovitz HE. Oral antidiabetic agents. In: Kahn RG, Weir GC, editors. Joslin\u2019s diabetes mellitus. 13th ed. Philadelphia (PA): Lea & Febiger, 1994: 509\u201329","edition":"13"},{"key":"BF03256197_CR2","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1001\/jama.287.3.360","volume":"287","author":"SE Inzucchi","year":"2002","unstructured":"Inzucchi SE. Oral antihyperglycemic therapy for type 2 diabetes. JAMA 2002; 287: 3609\u2013372","journal-title":"JAMA"},{"key":"BF03256197_CR3","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0025-7125(16)30709-X","volume":"72","author":"RE Ferner","year":"1988","unstructured":"Ferner RE. Oral hypoglycemic agents. Med Clin North Am 1988; 72: 1323\u201335","journal-title":"Med Clin North Am"},{"issue":"Suppl.1","key":"BF03256197_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2337\/diab.38.1.S13","volume":"38","author":"CG Groth","year":"1989","unstructured":"Groth CG, Tyden G, Ostman J. Fifteen years\u2019 experience with pancreas transplantation with pancreaticoenterostomy. Diabetes 1989; 38Suppl. 1: 13\u20135","journal-title":"Diabetes"},{"key":"BF03256197_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2165\/00003495-198937010-00004","volume":"37","author":"A Melander","year":"1989","unstructured":"Melander A, Bitzen PO, Faber O, et al. Sulphonylureas antidiabetic drugs: an update of their clinical pharmacology and rational therapeutic use. Drugs 1989; 37: 58\u201372","journal-title":"Drugs"},{"key":"BF03256197_CR6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.270.5239.1166","volume":"270","author":"LH Philipson","year":"1995","unstructured":"Philipson LH, Steiner DF. Pas de deux or more: the sulfonylurea receptor and K+ channels. Science 1995; 270: 1166\u201370","journal-title":"Science"},{"key":"BF03256197_CR7","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1677\/jme.0.0220113","volume":"22","author":"T Miki","year":"1999","unstructured":"Miki T, Nagashima K, Seino S. The structure and function of the ATP-sensitive K+ channel in insulin-secreting pancreatinc b-cells. J Mol Endocrinol 1999; 22: 113\u201323","journal-title":"J Mol Endocrinol"},{"key":"BF03256197_CR8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0140-6736(85)90403-9","volume":"8453","author":"NC Sturgess","year":"1985","unstructured":"Sturgess NC, Ashford NLJ, Cook DL, et al. The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 1985; 8453: 474\u20135","journal-title":"Lancet"},{"key":"BF03256197_CR9","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0889-8529(05)70264-4","volume":"26","author":"BR Zimmerman","year":"1997","unstructured":"Zimmerman BR. Sulfonylureas. Endocrinol Metab Clin North Am 1997; 26: 511\u201322","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF03256197_CR10","unstructured":"Quillen DM. Medications for the treatment of type 2 diabetes. American Academy of Family Physicians. 52nd Annual Scientific Assembly [online]. Available from URL: http:\/\/www.medscape.com\/Medscape\/CNO\/2000\/AAFP\/pnt-AAFP.html [Accessed 2002 Feb 9]"},{"key":"BF03256197_CR11","first-page":"493","volume":"296","author":"SW Shen","year":"1979","unstructured":"Shen SW, Bressler R. Clinical pharmacology of oral antidiabetic agents. N Engl J Med 1979; 296: 493\u20137","journal-title":"N Engl J Med"},{"key":"BF03256197_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","volume":"352","author":"UKPDS-33","year":"1998","unstructured":"UKPDS-33. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837\u201353","journal-title":"Lancet"},{"key":"BF03256197_CR13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/diacare.24.8.1411","volume":"24","author":"SJ Boccuzzi","year":"2001","unstructured":"Boccuzzi SJ, Wogen J, Fox J, et al. Utilization of oral hypoglycemic agents in a drug-insured US population. Diabetes Care 2001; 24: 1411\u20135","journal-title":"Diabetes Care"},{"key":"BF03256197_CR14","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF00278475","volume":"42","author":"J Benitez","year":"1992","unstructured":"Benitez J, Puerto AM, Diaz JA. Differences in antidiabetic drug utilization between three different health systems in the same national region. Eur J Clin Pharmacol 1992; 42: 151\u20134","journal-title":"Eur J Clin Pharmacol"},{"key":"BF03256197_CR15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0002-9343(76)90537-4","volume":"60","author":"JM Olefsky","year":"1976","unstructured":"Olefsky JM, Reaven GM. Effects of sulfonylurea therapy on insulin binding to mononuclear leukocytes of diabetic patients. Am J Med 1976; 60: 89\u201395","journal-title":"Am J Med"},{"key":"BF03256197_CR16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2337\/diabetes.38.2.205","volume":"38","author":"DB Jacobs","year":"1989","unstructured":"Jacobs DB, Hayes GR, Lockwood DH. In vitro effects of sulfonylureas on glucose transport and translocation of clusoe transporters in adipocytes from streptozocin-induced diabetic rats. Diabetes 1989; 38: 205\u201311","journal-title":"Diabetes"},{"key":"BF03256197_CR17","first-page":"43","volume":"6","author":"S Feld","year":"2000","unstructured":"Feld S. AACE diabetes guidelines. Endocr Pract 2000; 6: 43\u201367","journal-title":"Endocr Pract"},{"key":"BF03256197_CR18","first-page":"105","volume-title":"Horm Metab Res","author":"IW Campbell","year":"1985","unstructured":"Campbell IW. Metformin and the sulphonylureas: the comparative risk. Horm Metab Res 1985; Suppl. 15: 105\u201311"},{"key":"BF03256197_CR19","first-page":"69","volume":"45","author":"RM Walter Jr","year":"1990","unstructured":"Walter Jr RM. Hypoglycemia: still a risk in the elderly. Geriatrics 1990; 45: 69\u201375","journal-title":"Geriatrics"},{"key":"BF03256197_CR20","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/j.1532-5415.1996.tb03729.x","volume":"44","author":"RI Shorr","year":"1996","unstructured":"Shorr RI, Ray WA, Daugherty JR, et al. Individual sulfonylureas and serious hypoglycemia in older people. J Am Geriatr Soc 1996; 44: 751\u20135","journal-title":"J Am Geriatr Soc"},{"key":"BF03256197_CR21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bmj.296.6627.949","volume":"296","author":"RE Ferner","year":"1988","unstructured":"Ferner RE, Neil HAW. Sulphonylureas and hypoglycaemia. BMJ 1988; 296: 949\u201350","journal-title":"BMJ"},{"key":"BF03256197_CR22","first-page":"489","volume-title":"Joslin\u2019s diabetes mellitus","author":"B Widom","year":"1994","unstructured":"Widom B, Simonson DC. Iatrogenic hypoglycemia. In: Kahn R, Weir GC, editors. Joslin\u2019s diabetes mellitus. 13th ed. Philadelphia (PA): Lea & Febiger, 1994: 489\u2013507","edition":"13"},{"key":"BF03256197_CR23","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1001\/archinte.1997.00440320157015","volume":"157","author":"JH Anderson Jr","year":"1997","unstructured":"Anderson Jr JH, Brunelle RL, Keohane P, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with non-insulin-dependent diabetes mellitus. Multicenter Insulin Lispro Study Group. Arch Intern Med 1997; 157: 1249\u201355","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR24","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2337\/diabetes.39.12.1550","volume":"39","author":"TW Jones","year":"1990","unstructured":"Jones TW, McCarthy G, Tamborlane WV, et al. Mild hypoglycemia and impairment of brain stem and cortical evoked potentials in healthy subjects. Diabetes 1990; 39: 1550\u20135","journal-title":"Diabetes"},{"key":"BF03256197_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/bmj.306.6871.167","volume":"306","author":"A Maran","year":"1993","unstructured":"Maran A, Lomas J, Archibald H, et al. Double blind clinical and laboratory study of hypoglycaemia with human and porcine insulin in diabetic patients reporting hypoglycaemia un-awareness after transferring to human insulin. BMJ 1993; 306: 167\u201371","journal-title":"BMJ"},{"key":"BF03256197_CR26","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/(SICI)1096-9136(199711)14:11<929::AID-DIA477>3.0.CO;2-4","volume":"14","author":"RJ McCrimmon","year":"1997","unstructured":"McCrimmon RJ, Frier BM. Symptomatic and physiological responses to hypoglycaemia induced by human soluble insulin and the analogue Lispro human insulin. Diabet Med 1997; 14: 929\u201336","journal-title":"Diabet Med"},{"key":"BF03256197_CR27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00257338","volume":"24","author":"K Asplund","year":"1983","unstructured":"Asplund K, Wiholm BE, Lithner F. Glibenclamide-associated hypoglycaemia: a report on 57 cases. Diabetologia 1983; 24: 412\u20137","journal-title":"Diabetologia"},{"key":"BF03256197_CR28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2337\/diacare.13.4.458","volume":"13","author":"DJ Cox","year":"1990","unstructured":"Cox DJ, Gonder-Frederick L, Antoun B, et al. Psychobehavioral metabolic parameters of severe hypoglycemic episodes. Diabetes Care 1990; 13: 458\u20139","journal-title":"Diabetes Care"},{"key":"BF03256197_CR29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/BF03044682","volume":"93","author":"A Holstein","year":"1998","unstructured":"Holstein A, Lankes HG, Egberts EH. Diagnostic pitfalls in sulfonylurea-induced neuroglycopenic syndrome with hemiparesis, dysphasia and somnolence. Med Klin 1998; 93: 374\u20137","journal-title":"Med Klin"},{"key":"BF03256197_CR30","first-page":"93","volume-title":"Hypoglycemia and diabetes","author":"DA Hepburn","year":"1993","unstructured":"Hepburn DA. Symptoms of hypoglycemia. In: Frier BM, Fisher BM, editors. Hypoglycemia and diabetes. London: Edward Arnold, 1993: 93\u2013103"},{"key":"BF03256197_CR31","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.2337\/diacare.20.10.1543","volume":"20","author":"L Gonder-Frederick","year":"1997","unstructured":"Gonder-Frederick L, Cox D, Kovatchev B, et al. The psychosocial impact of severe hypoglycemic episodes on spouses of patients with IDDM. Diabetes Care 1997; 20: 1543\u20136","journal-title":"Diabetes Care"},{"key":"BF03256197_CR32","first-page":"117","volume":"85","author":"K Bielefeldt","year":"1990","unstructured":"Bielefeldt K, Reis HE. Hypoglycemia in type 2 diabetic patients. Med Klin 1990; 85: 117\u201320","journal-title":"Med Klin"},{"key":"BF03256197_CR33","doi-asserted-by":"crossref","first-page":"519","DOI":"10.2337\/diacare.16.2.519","volume":"16","author":"DJ Cox","year":"1993","unstructured":"Cox DJ, Gonder-Frederick L, Antoun B, et al. Perceived symptoms in the recognition of hypoglycemia. Diabetes Care 1993; 16: 519\u201327","journal-title":"Diabetes Care"},{"key":"BF03256197_CR34","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2337\/diabetes.43.12.1407","volume":"43","author":"L Gonder-Frederick","year":"1994","unstructured":"Gonder-Frederick L, Cox DJ, Driesen NR, et al. Individual differences in neurobehavioral disruption during mild and moderate hypoglycemia in adults with IDDM. Diabetes 1994; 43: 1407\u201312","journal-title":"Diabetes"},{"key":"BF03256197_CR35","doi-asserted-by":"crossref","first-page":"E67","DOI":"10.1152\/ajpcell.1991.260.1.C67","volume":"260","author":"A Mitrakou","year":"1991","unstructured":"Mitrakou A, Ryan C, Veneman T, et al. Hierarchy of glycemic thresholds for counter regulatory hormone secretion, symptoms and cerebral dysfunction. Am J Physiol 1991; 260: E67\u201374","journal-title":"Am J Physiol"},{"key":"BF03256197_CR36","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/diacare.17.7.734","volume":"17","author":"PE Cryer","year":"1994","unstructured":"Cryer PE, Fisher JN, Shamoon H. Hypoglycemia. Diabetes Care 1994; 17: 734\u201355","journal-title":"Diabetes Care"},{"key":"BF03256197_CR37","first-page":"347","volume-title":"Hypoglycaemia and diabetes: clinical and physiological aspects","author":"PE Lins","year":"1993","unstructured":"Lins PE, Adamson H. Neurologic manifestations of hypoglycemia. In: Frier BM, Fisher BM, editors. Hypoglycaemia and diabetes: clinical and physiological aspects. London: Edward Arnold, 1993: 347\u2013354"},{"key":"BF03256197_CR38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1464-5491.1985.tb00593.x","volume":"2","author":"WJ Mutch","year":"1985","unstructured":"Mutch WJ, Dingwall-Fordyce I. Is it a hypo?: knowledge of the symptoms of hypoglycaemia in elderly diabetic patients. Diabetic Med 1985; 2: 54\u20136","journal-title":"Diabetic Med"},{"issue":"12","key":"BF03256197_CR39","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1046\/j.1525-1497.1998.00243.x","volume":"13","author":"MD Ritholz","year":"1998","unstructured":"Ritholz MD, Jacobson AM. Living with hypoglycemia. J Gen Intern Med 1998; 13(12): 799\u2013804","journal-title":"J Gen Intern Med"},{"key":"BF03256197_CR40","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0889-8529(18)30395-5","volume":"18","author":"HS Seltzer","year":"1989","unstructured":"Seltzer HS. Drug-induced hypoglycemia: a review of 1418 cases. Endocrinol Metab Clin North Am 1989; 18: 163\u201383","journal-title":"Endocrinol Metab Clin North Am"},{"key":"BF03256197_CR41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2337\/diacare.8.2.141","volume":"8","author":"AF Casparie","year":"1985","unstructured":"Casparie AF, Elving LD. Severe hypoglycemia in diabetic patients: frequency, causes, and prevention. Diabetes Care 1985; 8: 141\u20135","journal-title":"Diabetes Care"},{"key":"BF03256197_CR42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.12.3.203","volume":"12","author":"AM Jennings","year":"1989","unstructured":"Jennings AM, Wilson RM, Ward JD. Symptomatic hypoglycemia in NIDDM patients treated with oral hypoglycemic agents. Diabetes Care 1989; 12: 203\u20138","journal-title":"Diabetes Care"},{"key":"BF03256197_CR43","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0895-4356(97)00024-3","volume":"50","author":"T Staa Van","year":"1997","unstructured":"Van Staa T, Abenhaim L, Monette J. Rates of hypoglycemia in users of sulfonylureas. J Clin Epidemiol 1997; 50: 735\u201341","journal-title":"J Clin Epidemiol"},{"key":"BF03256197_CR44","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diabetes.44.11.1249","volume":"44","author":"UKPDS 16","year":"1995","unstructured":"UKPDS 16. Overview of 6 years therapy of type II diabetes: a progressive disease. Diabetes 1995; 44: 1249\u201358","journal-title":"Diabetes"},{"key":"BF03256197_CR45","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00011","volume":"124","author":"R Turner","year":"1996","unstructured":"Turner R, Cull C, Holman H, et al. UKPDS17. Ann Intern Med 1996; 124 (Pt 2): 136\u201345","journal-title":"Ann Intern Med"},{"key":"BF03256197_CR46","doi-asserted-by":"crossref","unstructured":"UK prospective study of therapies of maturity-onset diabetes: I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting glucose and bodyweight over one year. Diabetologia 1983; 24: 404\u201311","DOI":"10.1007\/BF00257337"},{"key":"BF03256197_CR47","first-page":"111","volume":"15","author":"W Berger","year":"1985","unstructured":"Berger W. Incidence of severe side effects during therapy with sulfonylureas and biguanides. Horm Metab Res 1985; 15: 111\u20135","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR48","first-page":"717","volume-title":"Physicians\u2019 desk reference","author":"Hoeschst-Rousell Pharmaceuticals. Division of Aventis Pharmaceuticals Inc","year":"2002","unstructured":"Hoeschst-Rousell Pharmaceuticals. Division of Aventis Pharmaceuticals Inc. In: physicians\u2019 desk reference. 56th ed. Montvale (NJ): Medical Economics Company Inc., 2002: 717\u20139","edition":"56"},{"key":"BF03256197_CR49","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/diacare.19.11.1194","volume":"19","author":"J Rosenstock","year":"1996","unstructured":"Rosenstock J, Samols E, Muchmore DB, et al. Glimepiride, a new once-daily sulfonylurea: a double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group. Diabetes Care 1996; 19: 1194\u20139","journal-title":"Diabetes Care"},{"key":"BF03256197_CR50","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-2007-979831","volume":"28","author":"DG Dills","year":"1996","unstructured":"Dills DG, Schneider J, and the Glimepiride\/Glyburide Research Group. Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Horm Metab Res 1996; 28: 426\u20139","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR51","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/j.1552-4604.1998.tb04471.x","volume":"38","author":"DS Schade","year":"1998","unstructured":"Schade DS, Jovanovic L, Schneider J. A placebo-controlled, randomized study of glimepiride in patients with type 2 diabetes mellitus for whom diet therapy is unsuccessful. J Clin Pharmacol 1998; 38: 636\u201341","journal-title":"J Clin Pharmacol"},{"key":"BF03256197_CR52","doi-asserted-by":"crossref","first-page":"849","DOI":"10.2337\/diacare.19.8.849","volume":"19","author":"RB Goldberg","year":"1996","unstructured":"Goldberg RB, Schneider J, Holvey SM, et al. A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. Diabetes Care 1996; 19: 849\u201356","journal-title":"Diabetes Care"},{"key":"BF03256197_CR53","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-2007-979830","volume":"28","author":"KE Draeger","year":"1996","unstructured":"Draeger KE, Wenicke-Panten K, Lomp HJ, et al. Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide. Horm Metab Res 1996; 28: 419\u201325","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR54","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00000441-200003000-00003","volume":"319","author":"AE Kitabchi","year":"2000","unstructured":"Kitabchi AE, Kaminska E, Fisher JN, et al. Comparative efficacy and potency of long-term therapy with glipizide or glyburide in patients with type 2 diabetes mellitus. Am J Med Sci 2000; 319: 143\u20138","journal-title":"Am J Med Sci"},{"key":"BF03256197_CR55","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2337\/diacare.22.3.463","volume":"22","author":"BHR Wolffenbuttel","year":"1999","unstructured":"Wolffenbuttel BHR, Landgraf R. A 1-year multicenter randomized double-blind comparison of repaglinide and glyburide for the treatment of type 2 diabetes. Diabetes Care 1999; 22: 463\u20137","journal-title":"Diabetes Care"},{"key":"BF03256197_CR56","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.20.4.597","volume":"20","author":"DC Simonson","year":"1997","unstructured":"Simonson DC, Kourides IA, Feinglos M, et al. Efficacy, safety, and dose-response characteristics of glipizide gastrointestinal therapyetic system on glycemic control and insulin secretion in NIDDM: results of two multicenter, randomized, placebo-controlled clinical trials. Diabetes Care 1997; 20: 597\u2013606","journal-title":"Diabetes Care"},{"key":"BF03256197_CR57","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/diacare.17.11.1300","volume":"17","author":"LA Jaber","year":"1994","unstructured":"Jaber LA, Antal EJ, Slaughter RL, et al. Comparison of pharmacokinetics and pharmacodynamics of short- and long-term glyburide therapy in NIDDM. Diabetes Care 1994; 17: 1300\u20136","journal-title":"Diabetes Care"},{"key":"BF03256197_CR58","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2337\/diacare.20.4.597","volume":"20","author":"DC Simonson","year":"1997","unstructured":"Simonson DC, Kourides IA, Feinglos M, et al. Efficacy, safety and dose-response characteristics of glipizide gastrointestinal therapeutic system on glycemic control and insulin secretion in NIDDM: results of two multicenter, randomized, placebo-controlled clinical trials. Diabetes Care 1997; 20: 597\u2013606","journal-title":"Diabetes Care"},{"key":"BF03256197_CR59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2165\/00003495-199855040-00007","volume":"55","author":"HD Langtry","year":"1998","unstructured":"Langtry HD, Balfour JA. Glimepiride: a review of its use in the management of type 2 diabetes mellitus. Drugs 1998; 55: 563\u201384","journal-title":"Drugs"},{"key":"BF03256197_CR60","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00003088-199631020-00003","volume":"31","author":"AD Harrower","year":"1996","unstructured":"Harrower AD. Pharmacokinetcis of oral antihyperglycaemic agents in patients with renal insufficiency. Clin Pharmacokinet 1996; 31: 111\u20139","journal-title":"Clin Pharmacokinet"},{"key":"BF03256197_CR61","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1055\/s-2007-979833","volume":"28","author":"B Rosenkranz","year":"1996","unstructured":"Rosenkranz B. Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients. Horm Metab Res 1996; 28: 434\u20139","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR62","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archinte.1997.00440360095010","volume":"157","author":"RI Shorr","year":"1997","unstructured":"Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681\u20136","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR63","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0749-0690(18)30576-7","volume":"6","author":"MI Harris","year":"1990","unstructured":"Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990; 6: 703\u201319","journal-title":"Clin Geriatr Med"},{"key":"BF03256197_CR64","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/archinte.161.13.1653","volume":"161","author":"CD Miller","year":"2001","unstructured":"Miller CD, Phillips LS, Ziemer DC, et al. Hypoglycemia in patients with type 2 diabetes mellitus. Arch Intern Med 2001; 161: 1653\u20139","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR65","first-page":"409","volume":"26","author":"TYK Chang","year":"1997","unstructured":"Chang TYK, Cheung AYK. Predictors of relapse in elderly diabetic patients admitted with sulphonylureas-induced severe hypoglycaemic attacks. Age Ageing 1997; 26: 409\u201310","journal-title":"Age Ageing"},{"key":"BF03256197_CR66","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/archinte.1997.00440360095010","volume":"157","author":"RI Shorr","year":"1997","unstructured":"Shorr RI, Ray WA, Daugherty JR, et al. Incidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas. Arch Intern Med 1997; 157: 1681\u20136","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR67","first-page":"21","volume":"5","author":"HS Seltzer","year":"1979","unstructured":"Seltzer HS. Severe drug-induced hypoglycemia: a review. Compr Ther 1979; 5: 21\u20139","journal-title":"Compr Ther"},{"key":"BF03256197_CR68","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0163-7258(89)90031-4","volume":"42","author":"CJ Bailey","year":"1989","unstructured":"Bailey CJ, Flatt PR, Marks V. Drugs inducing hypoglycemia. Pharmacol Ther 1989; 42: 361\u201384","journal-title":"Pharmacol Ther"},{"key":"BF03256197_CR69","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/dmrr.235","volume":"17","author":"A Holstein","year":"2001","unstructured":"Holstein A, Plaschke A, Egberts EH. Lower incidence of severe hypoglycemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. Diabetes Metab Res Rev 2001; 17: 467\u201373","journal-title":"Diabetes Metab Res Rev"},{"key":"BF03256197_CR70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1001\/archinte.159.3.281","volume":"159","author":"H Ben-Ami","year":"1999","unstructured":"Ben-Ami H, Nagachandran P, Mendelson A, et al. Drug-induced hypoglycemic coma in 102 diabetic patients. Arch Intern Med 1999; 159: 281\u20134","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR71","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/diab.25.12.1129","volume":"25","author":"The University Group Diabetes Program","year":"1976","unstructured":"The University Group Diabetes Program. A study of the effect of hypoglycemic agents on vascular complications in patients with adult onset diabetes. VI: supplementary report on nonfatal events in patients treated with tolbutamide. Diabetes 1976; 25: 1129\u201353","journal-title":"Diabetes"},{"key":"BF03256197_CR72","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00251913","volume":"18","author":"C Kilo","year":"1980","unstructured":"Kilo C, Miller JP, Williamson JR. The crux of the University Group Diabetes Program: spurious results and biologically inappropriate data analysis. Diabetologia 1980; 18: 179\u201385","journal-title":"Diabetologia"},{"key":"BF03256197_CR73","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1055\/s-2007-979841","volume":"28","author":"K Geisen","year":"1996","unstructured":"Geisen K, Vegh A, Krause E, et al. Cardiovascular effects of conventional sulfonylureas and glimepiride. Horm Metab Res 1996; 28: 496\u2013507","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR74","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/S0735-1097(98)00038-2","volume":"31","author":"PA Brady","year":"1998","unstructured":"Brady PA, Terzic A. The sulfonylurea controversy: more questions from the heart. J Am Coll Cardiol 1998; 31: 950\u20136","journal-title":"J Am Coll Cardiol"},{"issue":"Suppl.2","key":"BF03256197_CR75","first-page":"7789","volume":"19","author":"University Group Diabetes Program","year":"1970","unstructured":"University Group Diabetes Program. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes: II. mortality results. Diabetes 1970; 19Suppl. 2: 7789\u2013830","journal-title":"Diabetes"},{"key":"BF03256197_CR76","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/305147a0","volume":"305","author":"A Norma","year":"1983","unstructured":"Norma A. ATP-regulated K+ channels in cardiac muscle. Nature 1983; 305: 147\u20138","journal-title":"Nature"},{"key":"BF03256197_CR77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/01.CIR.96.1.29","volume":"96","author":"JC Cleveland Jr","year":"1997","unstructured":"Cleveland Jr JC, Meldrum DR, Cain BS, et al. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium: two paradoxes revisited. Circulation 1997; 96: 29\u201332","journal-title":"Circulation"},{"key":"BF03256197_CR78","doi-asserted-by":"crossref","first-page":"H1797","DOI":"10.1152\/ajpcell.1993.265.6.C1489","volume":"265","author":"WF Jackson","year":"1993","unstructured":"Jackson WF. Arteriolar tone is determined by activity of ATP-sensitive potassium channels. Am J Physiol 1993; 265: H1797\u2013803","journal-title":"Am J Physiol"},{"key":"BF03256197_CR79","first-page":"H84","volume":"266","author":"T Narishige","year":"1994","unstructured":"Narishige T, Egashira K, Akatsuka Y, et al. Glibenclamide prevents coronary vasodilation induced by b1-adrenoceptor stimulation in dogs. Am J Physiol 1994; 266: H84\u201392","journal-title":"Am J Physiol"},{"key":"BF03256197_CR80","doi-asserted-by":"crossref","first-page":"28757","DOI":"10.1074\/jbc.M004818200","volume":"275","author":"M Matsuo","year":"2000","unstructured":"Matsuo M, Tanabe K, Kioka N, et al. Different binding properties and affinities for ATP and ADP among sulfonylurea receptor subtypes, SUR1, SUR2A and SUR2B. J Biol Chem 2000; 275: 28757\u201363","journal-title":"J Biol Chem"},{"key":"BF03256197_CR81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-2007-1003387","volume":"24","author":"U Panten","year":"1992","unstructured":"Panten U, Schwanstecher M, Schwanstecher C. Pancreatic and extrapancreatic sulfonylurea receptors. Horm Metab Res 1992; 24: 549\u201354","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR82","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2165\/00002512-200017050-00007","volume":"17","author":"R Ladgraf","year":"2000","unstructured":"Ladgraf R. Meglitinide analogues in the treatment of type 2 diabetes mellitus. Drugs Aging 2000; 17: 411\u201325","journal-title":"Drugs Aging"},{"key":"BF03256197_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0029-1211414","volume":"104","author":"U Panten","year":"1996","unstructured":"Panten U, Schwanstecher M, Schwanstecher C. Sulfonylurea receptors and mechanism of sulfonylurea action. Exp Clin Endocrinol Diabetes 1996; 104: 1\u20139","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"BF03256197_CR84","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1055\/s-2007-979837","volume":"28","author":"FM Ashcroft","year":"1996","unstructured":"Ashcroft FM. Mechanisms of the glycaemic effects of sulfonylureas. Horm Metab Res 1996; 28: 456\u201363","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR85","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diabetes.37.7.847","volume":"37","author":"AE Boyd III","year":"1988","unstructured":"Boyd III AE. Sulfonylurea receptors, ion channels, and fruit flies. Diabetes 1988; 37: 847\u201350","journal-title":"Diabetes"},{"key":"BF03256197_CR86","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.2337\/diacare.21.6.1024","volume":"21","author":"ZT Bloomgarden","year":"1998","unstructured":"Bloomgarden ZT. International Diabetes Federation Meeting, 1997: issues in the treatment of type 2 diabetes; sulfonylureas, metformin and troglitazone. Diabetes Care 1998; 21: 1024\u20135","journal-title":"Diabetes Care"},{"key":"BF03256197_CR87","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0735-1097(98)00557-9","volume":"33","author":"KN Garratt","year":"1999","unstructured":"Garratt KN, Brady PA, Hassinger NL, et al. Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33: 119\u201324","journal-title":"J Am Coll Cardiol"},{"key":"BF03256197_CR88","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1053\/euhj.1998.1153","volume":"19","author":"JH O\u2019Keefe","year":"1998","unstructured":"O\u2019Keefe JH, Blackstone EH, Sergeant P, et al. The optimal mode of coronary revascularization for diabetics. Eur Heart J 1998; 19: 1696\u2013703","journal-title":"Eur Heart J"},{"key":"BF03256197_CR89","first-page":"1355","volume":"267","author":"A Tosaki","year":"1993","unstructured":"Tosaki A, Szerdahelyi P, Engelman RM, et al. Potassium channel openers and blockers: do they possess proarrhythmic or anti-arrhythmic activity in ischemic and reperfused rat hearts? J Pharmacol Exp Ther 1993; 267: 1355\u201362","journal-title":"J Pharmacol Exp Ther"},{"key":"BF03256197_CR90","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1161\/01.RES.66.2.478","volume":"66","author":"PF Kantor","year":"1990","unstructured":"Kantor PF, Coetzee WA, Carmeliet EE, et al. Reduction of ischemic K+ loss and arrhythmias in rat hearts. Circ Res 1990; 66: 478\u201385","journal-title":"Circ Res"},{"key":"BF03256197_CR91","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00005344-199302000-00003","volume":"21","author":"GE Billman","year":"1993","unstructured":"Billman GE, Avendano CE, Halliwill JR, et al. The effects of the ATP dependent potassium channel antagonist, glyburide, on coronary blood flow and susceptibility to ventricular fibrillation in anaesthetized dogs. J Cardiovasc Pharmacol 1993; 21: 197\u2013204","journal-title":"J Cardiovasc Pharmacol"},{"key":"BF03256197_CR92","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1055\/s-2007-979845","volume":"28","author":"RJ Heine","year":"1996","unstructured":"Heine RJ. Role of sulfonylureas in non-insulin-dependent diabetes mellitus. Part II: \u2018The cons\u2019. Horm Metab Res 1996; 28: 522\u20136","journal-title":"Horm Metab Res"},{"key":"BF03256197_CR93","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1001\/archinte.1997.00440370028004","volume":"157","author":"S Dagogo-Jack","year":"1997","unstructured":"Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 1997; 157: 1802\u201317","journal-title":"Arch Intern Med"},{"key":"BF03256197_CR94","first-page":"820","volume":"35","author":"LW Hong","year":"2000","unstructured":"Hong LW, Wright JM. Risk of sulfonylurea drugs is underappreciated [letter]. J Am Coll Cardiol 2000; 35: 820","journal-title":"J Am Coll Cardiol"},{"key":"BF03256197_CR95","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diacare.17.10.1100","volume":"17","author":"LS Hermann","year":"1994","unstructured":"Hermann LS, Schersten B, Bitzen P, et al. Therapeutic comparison of metaformin and sulfonylurea, alone and in various combinations. Diabetes Care 1994; 17: 1100\u20139","journal-title":"Diabetes Care"},{"key":"BF03256197_CR96","doi-asserted-by":"crossref","unstructured":"United Kingdom Prospective Diabetes Study (UKPDS) 13. Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995; 310: 83\u20138","DOI":"10.1136\/bmj.310.6972.83"},{"key":"BF03256197_CR97","first-page":"1043","volume":"24","author":"M Kamien","year":"1995","unstructured":"Kamien M, Ward A, Mansfield F, et al. Patient practices, and satisfaction with GP care. Aust Fam Physician 1995; 24: 1043\u20139","journal-title":"Aust Fam Physician"},{"key":"BF03256197_CR98","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0168-8227(91)90090-Z","volume":"12","author":"HI Marsiaj","year":"1991","unstructured":"Marsiaj HI, Catalano C, Sum CF, et al. Management of newly diagnosed non-insulin-dependent (type 2) diabetes mellitus: a retrospective audit. Diabetes Res Clin Pract 1991; 12: 129\u201336","journal-title":"Diabetes Res Clin Pract"},{"key":"BF03256197_CR99","first-page":"394","volume":"20","author":"IW Campbell","year":"1994","unstructured":"Campbell IW, Menzies DG, Chalmers J, et al. One year comparative trial of metformin and glipizide in type 2 diabetes mellitus. Diabetes Metab 1994; 20: 394\u2013400","journal-title":"Diabetes Metab"},{"key":"BF03256197_CR100","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1056\/NEJM198911023211805","volume":"321","author":"JE Gerich","year":"1989","unstructured":"Gerich JE. Oral hypoglycemic agents. N Engl J Med 1989; 321: 1231\u201345","journal-title":"N Engl J Med"},{"key":"BF03256197_CR101","first-page":"741","volume-title":"Physicians\u2019 desk reference","author":"Hoeschst-Rousell Pharmaceuticals. Division of Aventis Pharmaceuticals Inc. In","year":"2002","unstructured":"Hoeschst-Rousell Pharmaceuticals. Division of Aventis Pharmaceuticals Inc. In: physicians\u2019 desk reference. 56th ed. Montvale (NJ): Medical Economics Company Inc., 2002: 741\u20132","edition":"56"},{"key":"BF03256197_CR102","first-page":"1096","volume":"23","author":"A Dusoleil","year":"1999","unstructured":"Dusoleil A, Condat B, Sobesky R, et al. Glimepiride-induced acute hepatitis. Gastroenterol Clin Biol 1999; 23: 1096\u20137","journal-title":"Gastroenterol Clin Biol"},{"key":"BF03256197_CR103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1042\/cs0730077","volume":"73","author":"PJ Hoskins","year":"1987","unstructured":"Hoskins PJ, Wiles PG, Volkman HP. Chlorpropamide alcohol flushing: a normal response? Clin Sci 1987; 73: 77\u201380","journal-title":"Clin Sci"},{"key":"BF03256197_CR104","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/00003495-198427040-00002","volume":"27","author":"B Holmes","year":"1984","unstructured":"Holmes B, Heel RC, Brogden RN, et al. Gliclazide: a preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus. Drugs 1984; 27: 301\u201327","journal-title":"Drugs"},{"key":"BF03256197_CR105","first-page":"23","volume":"1","author":"BJ Paice","year":"1985","unstructured":"Paice BJ, Paterson KR, Lawson DH. Undesired effects of sulfonylurea drugs. Adverse Drug React Acute Poisoning Rev 1985; 1: 23\u201336","journal-title":"Adverse Drug React Acute Poisoning Rev"},{"key":"BF03256197_CR106","first-page":"311","volume":"46","author":"E Girardin","year":"1991","unstructured":"Girardin E, Conte Devolx B. Mode of action of hypoglycemic sulfanilamides. Therapie 1991; 46: 311\u20134","journal-title":"Therapie"},{"key":"BF03256197_CR107","doi-asserted-by":"crossref","first-page":"904","DOI":"10.2337\/diacare.13.8.904b","volume":"13","author":"SL Abbate","year":"1990","unstructured":"Abbate SL, Hoogwerf BJ. Hemolytic anemia associated with sulfonylurea use: case study and review of literature. Diabetes Care 1990; 13: 904\u20135","journal-title":"Diabetes Care"},{"key":"BF03256197_CR108","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1345\/aph.19148","volume":"34","author":"G Cartron","year":"2000","unstructured":"Cartron G, Jonville-Bera AP, Autret-Leca E, et al. Glimepiride-induced thrombocytopenic purpura [letter]. Ann Pharmacother 2000; 34: 120","journal-title":"Ann Pharmacother"},{"issue":"3","key":"BF03256197_CR109","first-page":"341","volume":"20","author":"KG Alberti","year":"1994","unstructured":"Alberti KG. Gliclazide: review of metabolic and vascular action. Diabetes Metab 1994; 20 (3 Pt 2): 341\u20138","journal-title":"Diabetes Metab"},{"key":"BF03256197_CR110","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0006-2952(92)90404-7","volume":"44","author":"Y Ozaki","year":"1992","unstructured":"Ozaki Y, Yatomi Y, Kume S. Effects of oral hypoglycemic agents on platelet functions. Biochem Pharmacol 1992; 44: 687\u201391","journal-title":"Biochem Pharmacol"},{"key":"BF03256197_CR111","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0168-8227(89)90105-8","volume":"7","author":"A Mizuno","year":"1989","unstructured":"Mizuno A, Yano M, Isobre J, et al. Inhibitory action of gliclazide on platelet functions. Diabetes Res Clin Pract 1989; 7: 141\u20137","journal-title":"Diabetes Res Clin Pract"},{"key":"BF03256197_CR112","first-page":"849","volume":"60","author":"JM Lightman","year":"1989","unstructured":"Lightman JM, Townsend JC, Selvin GJ. Ocular effects of second generation oral hypoglycemic agents. J Am Optom Assoc 1989; 60: 849\u201353","journal-title":"J Am Optom Assoc"},{"key":"BF03256197_CR113","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1056\/NEJM197101142840202","volume":"284","author":"PN Weissman","year":"1971","unstructured":"Weissman PN, Shenkman L, Gregerman RI. Chlorpropamide hyponatremia: drug-induced inappropriate antidiuretic hormone activity. N Engl J Med 1971; 284: 65\u201371","journal-title":"N Engl J Med"},{"key":"BF03256197_CR114","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0026-0495(73)90029-2","volume":"22","author":"AM Moses","year":"1973","unstructured":"Moses AM, Numann P, Miller M. Mechanism of chlorpropamide-induced antidiuresis in man: evidence for release of ADH and enhancement of peripheral action. Metabolism 1973; 22: 59\u201366","journal-title":"Metabolism"},{"key":"BF03256197_CR115","doi-asserted-by":"crossref","first-page":"541","DOI":"10.7326\/0003-4819-78-4-541","volume":"78","author":"AM Moses","year":"1973","unstructured":"Moses AM, Howanitz J, Miller M. Diuretic action of three sulfonylurea drugs. Ann Intern Med 1973; 78: 541\u20134","journal-title":"Ann Intern Med"}],"container-title":["Adverse Drug Reactions and Toxicological Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256197.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03256197\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03256197","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T18:26:00Z","timestamp":1562091960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03256197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,12]]}},"alternative-id":["BF03256197"],"URL":"https:\/\/doi.org\/10.1007\/bf03256197","relation":{},"ISSN":["0964-198X"],"issn-type":[{"value":"0964-198X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,12]]}}}